Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
MSD Initiates IDeate-Prostate01 Phase III Trial of Ifinatamab Deruxtecan for mCRPC
June 20, 2025
Company
Drug
Changchun BCHT Gains NMPA Approval for BK-01 Adjuvanted Influenza Vaccine
June 20, 2025
Company
Drug
NMPA’s CDE Reports 4,900 Clinical Trial Filings for Innovative Drugs in 2024
June 20, 2025
Company
Deals
Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project
June 20, 2025
Company
Drug
CDE Issues New Requirements for IND Applications of Innovative Drugs
June 20, 2025
Company
Deals
ADVANZ PHARMA Acquires Bayer’s Testoviron Commercial Rights in Key Markets
June 20, 2025
Company
Deals
Medtide’s IPO Raises HKD 514 Million to Expand Global Peptide CRDMO Services
June 20, 2025
Company
Drug
Shanghai Innogen’s Diabetes Drug Patent for Efsubaglutide Alfa Fully Invalidated
June 20, 2025
Company
Drug
Shandong Xinhua Pharma Initiates Phase II Study of OAB-14 for Alzheimer’s Disease
June 20, 2025
Company
Medical Device
Bayer Wins Beijing MPA Approval for MEDRAD Stellant D-CE Medical Device
June 20, 2025
Company
Drug
Joincare Pharma Gets NMPA Green Light for Pediatric Influenza Drug JKN2301
June 20, 2025
Company
Deals
Abbott Partners with Abu Dhabi Department of Health to Localize Pharma Production and Digital Health Solutions
June 20, 2025
1
2
…
128
129
130
131
132
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
